Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Dose density in adjuvant chemotherapy for breast cancer.
Citron ML. Citron ML. Cancer Invest. 2004;22(4):555-68. doi: 10.1081/cnv-200027134. Cancer Invest. 2004. PMID: 15565814 Review.
Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine.
Belanich M, Pastor M, Randall T, Guerra D, Kibitel J, Alas L, Li B, Citron M, Wasserman P, White A, Eyre H, Jaeckle K, Schulman S, Rector D, Prados M, Coons S, Shapiro W, Yarosh D. Belanich M, et al. Cancer Res. 1996 Feb 15;56(4):783-8. Cancer Res. 1996. PMID: 8631014 Clinical Trial.
A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain.
Hoffman M, Xu JC, Smith C, Fanelli C, Pascal V, Degaetano C, Meenan G, Lehrer M, Lesser M, Citron M. Hoffman M, et al. Cancer Invest. 1997;15(6):542-7. doi: 10.3109/07357909709047595. Cancer Invest. 1997. PMID: 9412659 Clinical Trial.
O6-methylguanine-DNA methyltransferase in human normal and malignant lung tissues.
Citron M, Schoenhaus M, Graver M, Hoffman M, Lewis M, Wasserman P, Niederland M, Kahn L, White A, Yarosh D. Citron M, et al. Cancer Invest. 1993;11(3):258-63. doi: 10.3109/07357909309024850. Cancer Invest. 1993. PMID: 8485648 No abstract available.
O6-methylguanine-DNA methyltransferase in normal and malignant tissue of the breast.
Citron M, Schoenhaus M, Rothenberg H, Kostroff K, Wasserman P, Kahn L, White A, Burns G, Held D, Yarosh D. Citron M, et al. Cancer Invest. 1994;12(6):605-10. doi: 10.3109/07357909409023045. Cancer Invest. 1994. PMID: 7994595
5-Fluorouracil pharmacokinetics in patients with metastatic colorectal carcinoma after high-dose leucovorin.
Stein TA, Burns GP, Bailey B, Citron ML. Stein TA, et al. Among authors: citron ml. Cancer Invest. 1994;12(4):375-8. doi: 10.3109/07357909409038225. Cancer Invest. 1994. PMID: 8032956
Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.
Citron ML, Kaplan R, Parris WC, Croghan MK, Herbst LH, Rosenbluth RJ, Reder RF, Slagle NS, Buckley BJ, Kaiko RF. Citron ML, et al. Cancer Invest. 1998;16(8):562-71. doi: 10.3109/07357909809032886. Cancer Invest. 1998. PMID: 9844616 Clinical Trial.
Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
Citron ML, Modeas C, Propert K, Goutsou M, Green MR. Citron ML, et al. Cancer Invest. 1992;10(3):215-9. doi: 10.3109/07357909209032763. Cancer Invest. 1992. PMID: 1316201 Clinical Trial.
Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use.
Citron ML, Kalra JM, Seltzer VL, Chen S, Hoffman M, Walczak MB. Citron ML, et al. Cancer Invest. 1992;10(5):335-41. doi: 10.3109/07357909209024792. Cancer Invest. 1992. PMID: 1393684 Clinical Trial.
Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs.
Muscat JE, Chen SQ, Richie JP Jr, Altorki NK, Citron M, Olson S, Neugut AI, Stellman SD. Muscat JE, et al. Cancer. 2003 Apr 1;97(7):1732-6. doi: 10.1002/cncr.11242. Cancer. 2003. PMID: 12655530
54 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page